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ABSTRACT:
Heroin-induced leukoencephalopathy comes under the category of Toxic leukoencephalopathies. We report the case
of middle-aged gentleman with the history of polysubstance abuse who presented with recurrent falls, difficulty in
walking and drowsiness. Diffuse white matter changes were appreciated on MRI Brain with sparing of cerebellum. In
context of his history of inhalational heroin abuse with extensive symmetrical white matter changes in cerebrum, a
diagnosis of heroin induced toxic leukoencephalopathy was made.
INTRODUCTION:
Leukoencephalopathy is a syndrome of neurologic
deficits including alteration of mental status caused by
pathological changes in cerebral white matter. The term
“Toxic leukoencephalopathy” include a wide range of
toxins
and
clinical
presentations.
Toxic
leukoencephalopathy secondary to heroin was first
described by Wolters in 1982 after an outbreak in
Netherlands(1). Since then number of cases have been
reported. Diagnosis requires neurobehavioral deficits,
exposure to toxin and specific MRI Brain changes
suggestive of white matter disease. Our case fulfilled
the diagnostic criteria for toxic leukoencephalopathy.
Other causes of leukoencephalopathy have been
excluded by detailed history and thorough
investigations.

of intake. Literature review revealed that intravenous
heroin abuse is associated with hypoxic-ischemic
encephalopathy while inhalational heroin is more
related to toxic leukoencephalopathy pathologically
termed as spongiform leukoencephalopathy. (5,6)
Clinical presentation varies from stupor, coma and
death after a latent period of hours days to months
following exposure of heroin. Three stages frequently
described in literature. Clinical features of initial stage
include motor restlessness, pseudobulbar speech and
cerebellar ataxia followed by intermediate stage which
includes rapid worsening of cerebellar symptoms,
hyperactive
reflexes,
spastic
hemiplegia
or
quadriplegia, myoclonus and chorea. (7)
Pathologically there is spongiform degeneration of
white matter especially the corticospinal and solitary
tracts with associated multivacuolar degeneration of
oligodendrocytes on histopathology. (8,9)

BACKGROUND:
Among the opioids Heroin is the most common illicit
drug of abuse and has significant neurological adverse
effects. (2) Mechanism of action includes activation of
three types of receptors mu, kappa and epsilon.
Stimulation of mu receptor results in respiratory
depression, miosis, euphoria and respiratory
depression while stimulation of later two contributes to
psychomimetic effects and dysphoria(3)

Neuroimaging is pathognomic which include cerebellar
white matter, cerebellar and cerebral peduncles,
posterior limb of internal capsule and centrum
semiovale with sparing of U-fibres.(10,11)Symmetry of
signals points towards toxic or metabolic etiology.
Radiological sparing of infratentorial region is seen in
our patient. The exact cause is unknown. Blasel et al
described cases in which there was only supratentorial
involvement and sparing of infratentorial structures.
Similarly a recent case report from India showed
sparing of infratentorial structures as well. In all these

Heroin can be abused either in injection, oral or
inhalational form. “Chasing the dragon” refers to
inhaling the smoke(pyrolysate vapors) from heated
heroin on a piece of foil(4) There is some variability in
the range of neurological complications related to route
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and delta receptors with combined effects incuding
euphoria and drowsiness, this is typically from
activation of opiod Mu receptors located at the nucleus
accumbens, this particular characteristic of the group is
famous among drug abusers who seek euphoric effects
while attempting to avoid withdrawal sideeffects.14,15
Heroin, a diacetyl derivative of morphine, with its
common usage among drug addicts varies in its form of
consumption
for
instance;
intravenously,
subcutaneously, smoked, sniffed or inhaled. When
talking about common medical related complications in
addition to is psychosocial degeneration are
encephalopathy, transverse myelitis, myelopathy,
cerebrla infarctions, meningitis, cerebral abscess,
mycotic aneurysms, myopathies and plexopathies.16
The clinical spectrum has been defined to vary over a
wide range from a more favourable outcome to
culmination to death in approximately 25%of reported
cases.17 In the acute stage neurologic symptoms are
more prevalent for example motor restlessness, apathy,
bradyphrenia, cerebellar speech disturbances and
ataxia, this may be followed by an intermediate stage
characterized with rapid worsening of cerebellar
symptoms with prominence of exaggeration of deep
tendon reflexes and additional pathologic reflexes,
spastic hemiparesis, tremor and myoclonic jerks or
choreoathetoid movement disorders.18 Finally, the
terminal stage may consist of vegetative dysregulation
spasmodic stretching, hypotonia and akinetic
mutism.19 This particular pattern of symptomatology
has been observed in our case as well.

above mentioned cases the heroin was abused in
inhalational form. (10,11)
CASE REPORT
34 year old gentleman with the ten years history of
polysubstance abuse predominantly inhalational
heroin, alcohol and benzodiazepines presented with
history of gait imbalance, frequent falls, dysarthria and
drowsiness for 2 weeks. Brothers narrated this history
and added that the patient used to stay outside home
for the most of his time. He is married with four
children. He never took any responsibility as far as his
family or home is concern. His Children were taken care
of by their paternal uncles. In between these ten years
he tried to leave addiction once or twice. He was
habitual of taking hand full of benzodiazepines. These
drugs added aggression to his personality to an extent
of physical and verbal abuse. On examination in clinic
he was drowsy but arousable on verbal command. Had
severe dysarthria. Moving all four limbs spontaneously.
Reflexes were brisk. No clonus. Plantars were flexor. He
was kept on benzodiazepines and antipsychotics for
control of withdrawal symptoms.
MRI brain with contrast showed diffuse symmetrical
signals supratentorially involving white matter sparing
cerebellum and brainstem. Predominantly on T2 and
Flair images. No diffusion restriction. No post contrast
enhancement.
CSF studies were normal. His antipsychotic
medications were adjusted and antibiotic was started
for possible aspiration pneumonia. HIV and VDRL found
to be negative. Neurological assessment following
above management showed significant improvement in
mentation. At that time neurology team tried to do
certain cognitive tests. Overall impression was labile
mood, inappropriate replies, failed to do serial 7 and
positive primitive reflexes. Cranial nerves were intact
grossly. Action fine tremors were appreciated in all four
limbs. Tone was increased.
Reflexes remained
exaggerated. Gait was apraxic and broad based.
Patient’s attendants were guided regarding changes in
MRI brain and variable prognosis. Strict abstinence
from Heroin was advised. He was discharged home with
rehabilitation measures.

A rare complication of inhalational form of heroin can
be spongiform leucoencephalopathy, reported first by
Wolters et al.17 in 1982, though this complication is
very scarce in literature only 56 cases been reported in
literature and has mainly been related to the additives
that becomes active after being burnt and pertains to
its toxic effects, this was seen in our patient using
inhalational form of abuse of this drug. These additives
as defined in literature are, “caffeine, phenobarbitone,
methaqualone, procaine, piracetam, and lignocaine”.20
This phenomenon of leucoencephalopathy has been so
far mainly been associated to inhalational form of
abuse. A reason explaining such phenomenon could be
related to the dose of intake, as it is more when using
the inhalational form by abuser, whereas other forms of
abuse may not be the culprit so far.21

DISCUSSION:
The group of drugs collectively includes heroin,
morphine, hydrocodones, oxycodone, hydromorphine,
codeine as well as other narcotics such as phentanyl,
meperidine and opium.13 When this particular group is
used for medical purposes, the most important role is
as pain killer, which comes from activation of kappa
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“vacuolar degeneration of cerebral white matter tracts”,
when viewing with electron microscopy it appears as
“fluid entrapment between myelin lamellae and
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absence of demyelination in these patients.”22

posthypoxic leukoencephalopathy. American
journal of neuroradiology. 2006 Sep
1;27(8):1763-5.

Magnetic resonance imaging(MRI) when performed in
such patients shows bilateral symmetrical hyperintense
lesions in the white matter of cerebrum and cerebellum
on T2-weighted images. Blasel et al, defined mainly
cerebral involvement and complete sparing of
infratentorial structures in his three patients, this
pattern was observed in our patient too.23
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MRI BRAIN T2 SEQUENCE (SYMMETRICAL
PERIVENTRICULAR HYPERINTENSITIES)

MRI BRAIN FLAIR SEQUENCE SHOWING PERIVENTRICULAR HYPERINTESNSITIES
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